Monday, May 29, 2023
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) to require signed disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME. Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity. Faculty are required to disclose only those relationships that are relevant to their specific presentation. The following relationships have been reported for this activity:
Associate Professor, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland
There are no prerequisites. This activity is intended for physicians and other healthcare providers who are directly involved in the treatment of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections.
The goal of this activity is to explore current knowledge, understanding, and practice approaches with respect to diagnosis and application of the most current guidelines for treatment of MRSA infections.
Upon completion of this activity, participants will be able to:
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) to require signed disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME. Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity. Faculty are required to disclose only those relationships that are relevant to their specific presentation. The following relationships have been reported for this activity:
Associate Professor, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Johns Hopkins School of Medicine designates this educational activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Estimated time to complete this activity: 1 hour.
The Johns Hopkins School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
Johns Hopkins Privacy Policy
The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protect the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine's CME program. CME collects only the information necessary to provide you with the services that you request.
Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Awarded 1.00 contact hour(s) of continuing nursing education for RNs and APNs; 0.50 contact hours are in the area of pharmacology.
Accreditation of this program does not imply endorsement by either Medscape, LLC or ANCC.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CME/CE Released: 12/21/2010
Valid for credit through: 12/21/2011
processing....
 |
A 55-year-old man with diabetes and hypertension is admitted to the hospital for coronary artery bypass graft (CABG) surgery. He has a left internal mammary artery graft to the left anterior descending artery and saphenous vein grafts to the left circumflex artery and right coronary artery. The procedure is completed in 3 hours. Postoperatively, his blood glucose levels were > 300 mg/dL on 3 occasions. While he was in the intensive care unit, a routine nasal swab was taken for Staphylococcus aureus screening. He was found to be colonized with methicillin-resistant S aureus (MRSA) susceptible to vancomycin, clindamycin, trimethoprim/sulfamethoxazole, linezolid, and tetracycline. He did well and was discharged to home on postoperative day 6.
